ADK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.558600E-01
Normal-vs-Stage2
8.479800E-01
Normal-vs-Stage3
5.106800E-01
Normal-vs-Stage4
5.077600E-01
Stage1-vs-Stage2
6.607400E-01
Stage1-vs-Stage3
5.580400E-01
Stage1-vs-Stage4
7.203400E-01
Stage2-vs-Stage3
3.727600E-01
Stage2-vs-Stage4
5.329600E-01
Stage3-vs-Stage4
7.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.476600E-01
Normal-vs-AfricanAmerican
5.208800E-01
Normal-vs-Asian
1.541440E-01
Caucasian-vs-AfricanAmerican
4.261600E-01
Caucasian-vs-Asian
2.937800E-03
AfricanAmerican-vs-Asian
1.532840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.204200E-01
Normal-vs-Female
9.405200E-01
Male-vs-Female
5.835800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.212400E-01
Normal-vs-Age(41-60Yrs)
5.949000E-01
Normal-vs-Age(61-80Yrs)
9.187000E-01
Normal-vs-Age(81-100Yrs)
7.297200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.099600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.010600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.225600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.219600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.477000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.890800E-01
Normal-vs-Daily Drinker
7.217800E-01
Normal-vs-Weekly Drinker
9.327800E-01
Normal-vs-Occasional Drinker
6.472400E-01
Normal-vs-Social Drinker
5.732800E-01
Non Drinker-vs-Daily Drinker
5.965800E-01
Non Drinker-vs-Weekly Drinker
7.572200E-01
Non Drinker-vs-Occasional Drinker
6.260200E-01
Non Drinker-vs-Social Drinker
7.543800E-01
Daily Drinker-vs-Weekly Drinker
4.296400E-01
Daily Drinker-vs-Occasional Drinker
9.044600E-01
Daily Drinker-vs-Social Drinker
8.824800E-01
Weekly Drinker-vs-Occasional Drinker
3.936600E-01
Weekly Drinker-vs-Social Drinker
5.588000E-01
Occasional Drinker-vs-Social Drinker
9.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.530800E-01
Normal-vs-Grade 2
1.772160E-01
Normal-vs-Grade 3
2.164200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.394200E-02
Grade 1-vs-Grade 3
1.734040E-02
Grade 1-vs-Grade 4
3.530800E-01
Grade 2-vs-Grade 3
3.997200E-01
Grade 2-vs-Grade 4
1.772160E-01
Grade 3-vs-Grade 4
2.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.263800E-01
Normal-vs-NonDiabetic
8.670600E-01
Diabetic-vs-NonDiabetic
9.032200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.265600E-01
Normal-vs-NoPancreatitis
8.526000E-01
Pancreatitis-vs-NoPancreatitis
3.557600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.967000E-01
Normal-vs-N1
8.566800E-01
N0-vs-N1
7.221400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.790000E-01
Normal-vs-TP53-NonMutant
9.372800E-01
TP53-Mutant-vs-TP53-NonMutant
8.769600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
